Seigo Izumo, MD Senior Vice President, Global Head of Regenerative Medicine Unit & Head of Scientific Affairs Japan, Takeda Pharmaceutical Company Ltd. Dr. Seigo Izumo is Senior Vice President, Global Head of Regenerative Medicine Unit and Head of Scientific Affairs Japan at Takeda Pharmaceutical Company. He is responsible for Takeda’s strategic initiative [...]
Organised in partnership with: Advanced Therapies – Opportunities and Challenges 14th November, London Speakers Richard Barker Founding Director, Centre for the Advancement of Sustainable Medical Innovation (CASMI) Biography Steve Bates Chief Executive Officer, [...]
Organised in partnership with: Advanced Therapies – Opportunities and Challenges 14th November, London Conference BMA House Tavistock Square, Bloomsbury, London WC1H 9JP Directions: http://www.bmahouse.org.uk/contact-or-find-us Need a hotel? We don't have an [...]
Organised in partnership with: Advanced Therapies – Opportunities and Challenges 14th November, London Agenda: 14 November 2017 - British Medical Association, London 8:30 Registration 9:00 Introduction by Conference Host, Seigo Izumo, Senior Vice President for Regenerative Medicine, Takeda [...]
14th November 2017, London
BMA House
Tavistock Square
London-WC1H 9JP
A European perspective to accelerate Advanced Therapies Gathering the World’s Thought Leaders in Advanced Therapies.
An interview with Ain Aaviksoo, Deputy General Secretary on eServices and Innovation, Ministry of Social Affairs, Estonia.
A key aim of the Presidency is to promote Digital Europe. In eHealth the goal will be to highlight how digital technologies can contribute to the sustainability and resilience of healthcare systems.
Vital Transformation recently interviewed TiGenix CEO Eduardo Bravo and President of the European Biopharmaceutical Enterprises (EBE) on the implications of this lack of liquidity in Europe.
An interview with Peeter Ross, professor at Tallinn University of Technology
As a participant in eight different EU projects, Peeter Ross, professor at Tallinn University of Technology, can fairly be described as a veteran of European ehealth research.
An interview with Simon Lovestone, Professor of Translational Neuroscience at Oxford University, UKMaking data repositories visible and easy to access is transforming translational research in Alzheimer’s disease. “You can answer questions you couldn’t before,” says Simon Lovestone, academic lead of the programme
An Interview with Nigel Hughes, Scientific Director, Quantitative Sciences at Janssen Research and Development By removing barriers to data exchange, EMIF has provided potent demonstrations of the power of pooling resources in Alzheimer’s disease and metabolic disorders. These exemplars are incentivising data sharing, says Nigel Hughes